![]() |
|
|
|
| | | |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1
.
SEC ADMINISTRATIVE PROCEEDING
|
EXTRACTED KEY WORDS
SALES BOSTON JAPAN EXCHANGE ACT REPORTS FALSE SALES COMMISSION DISTRIBUTORS ACCOUNTS VIOLATIONS NET INCOME INTERNAL CONTROLS GOODS BOOKS SECURITIES BOSTON SCIENTIFIC CORPORATION PURSUANT INDEPENDENT DISTRIBUTORS SALES MANAGERS RESTATEMENT FINDINGS BOSTON JAPAN EMPLOYEES ADEQUATE SYSTEM UNDERSTATEMENTS NET LOSSES QUARTERLY REPORTS FINANCIAL STATEMENTS REVENUE MISSTATEMENTS TRANSACTIONS |
UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 43183 / August 21, 2000
ACCOUNTING AND AUDITING ENFORCEMENT
Release No. 1295 / August 21, 2000
ADMINISTRATIVE PROCEEDING
File No. 3-10272
In the Matter of
BOSTON SCIENTIFIC CORPORATION,
Respondent.
ORDER INSTITUTING PROCEEDINGS
PURSUANT TO SECTION 21C OF THE
SECURITIES EXCHANGE ACT OF 1934,
MAKING FINDINGS AND
IMPOSING A CEASE-AND-
DESIST ORDER
I.
The Securities and Exchange Commission ("Commission") deems it
appropriate that cease-and-desist proceedings be, and hereby are,
instituted against Boston Scientific Corporation ("Boston Scientific")
pursuant to Section 21C of the Securities Exchange Act of 1934
("Exchange Act").
II.
In anticipation of the institution of these proceedings, Boston
Scientific has submitted an Offer of Settlement ("Offer"), which the
Commission has determined to accept. Solely for the purpose of these
proceedings, and any other proceedings brought by or on behalf of the
Commission, or to which the Commission is a party, and without
admitting or denying the findings, except those findings pertaining to
the jurisdiction of the Commission over it and over the subject matter
of these proceedings, which Boston Scientific admits, Boston
Scientific by its Offer consents to the entry of this Order
Instituting Proceedings Pursuant to Section 21C of the Exchange Act,
Making Findings, and Imposing Cease-And-Desist Order ("Order").
SNIPPETS:
|
| | | |